HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Treatment of primary Sjogren syndrome with rituximab: extended follow-up, safety and efficacy of retreatment.

AuthorsJ M Meijer, J Pijpe, A Vissink, C G M Kallenberg, H Bootsma
JournalAnnals of the rheumatic diseases (Ann Rheum Dis) Vol. 68 Issue 2 Pg. 284-5 (Feb 2009) ISSN: 1468-2060 [Electronic] England
PMID19139205 (Publication Type: Letter)
Chemical References
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Immunosuppressive Agents
  • Rituximab
Topics
  • Antibodies, Monoclonal (therapeutic use)
  • Antibodies, Monoclonal, Murine-Derived
  • Follow-Up Studies
  • Humans
  • Immunosuppressive Agents (therapeutic use)
  • Retreatment
  • Rituximab
  • Sjogren's Syndrome (drug therapy)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: